Thakur C P
Kala-azar Research Centre, Patna, India.
Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):668-70. doi: 10.1016/s0035-9203(97)90516-2.
Two hundred and seventy patients with febrile splenomegaly and coming from areas where visceral leishmaniasis (VL; kala-azar) is endemic and in whom the diagnosis of kala-azar was strongly suspected were randomly divided into 3 groups, subjected to splenic aspiration by the intercostal route, splenic aspiration by the abdominal route, and bone marrow aspiration, respectively, for demonstration of amastigotes. Pain immediately after aspiration, requiring a few analgesic tablets, occurred in 8, 16 and 20 patients of the 3 groups, respectively. Pain on the day after aspiration was reported by 2, 4 and 6 patients, respectively. One patient, in the abdominal group, developed gastro-intestinal haemorrhage but this was managed with blood transfusion; he was not suffering from VL. No patient died. The abdominal route of splenic aspiration was not feasible in 12 patients (13%), as their spleen size was less than 3 cm, and they were subsequently aspirated by the intercostal route. On the first aspiration, amastigotes were seen in 68 patients (76%) in the intercostal group, 64 patients (71%) in the abdominal group and 42 patients (46%) in the bone marrow group. Two weeks later, 15 patients (17%) in the bone marrow group and in whom amastigotes had not been detected, but whose fever continued, were subjected to intercostal splenic aspiration and amastigotes were detected. After 2 months, 3 patients in the intercostal group and 4 patients in the abdominal group gave positive aspirates, and 2 patients in the intercostal group, one in the abdominal group, and one in the bone marrow group did so at the third aspiration. Thus only 200 (74%) of 270 patients were suffering from VL. It was concluded that, with some precautions, splenic aspiration is a safe and easy method for the diagnosis of VL, and the intercostal route is preferred because it is feasible in a larger proportion of cases and anatomically safer than the abdominal route, and it gives a positive result more often than bone marrow aspiration.
270例来自内脏利什曼病(VL;黑热病)流行地区、高度怀疑患有黑热病的发热性脾肿大患者被随机分为3组,分别采用肋间途径脾穿刺、经腹途径脾穿刺和骨髓穿刺来查找无鞭毛体。穿刺后立即出现疼痛、需服用几片镇痛药的情况在3组中分别有8例、16例和20例。穿刺后次日出现疼痛的分别有2例、4例和6例。经腹组有1例患者发生胃肠道出血,但经输血治疗;该患者未患VL。无患者死亡。12例患者(13%)经腹途径脾穿刺不可行,因为其脾脏大小小于3 cm,随后改行肋间途径穿刺。首次穿刺时,肋间组68例患者(76%)、经腹组64例患者(71%)和骨髓组42例患者(46%)查见无鞭毛体。两周后,骨髓组15例未检测到无鞭毛体但仍发热的患者接受肋间途径脾穿刺,查见无鞭毛体。2个月后,肋间组3例患者、经腹组4例患者穿刺结果呈阳性,肋间组2例患者、经腹组1例患者和骨髓组1例患者在第三次穿刺时结果呈阳性。因此,270例患者中仅200例(74%)患有VL。结论是,采取一些预防措施后,脾穿刺是诊断VL的一种安全、简便的方法,肋间途径更可取,因为在更大比例的病例中可行,且在解剖学上比经腹途径更安全,其阳性结果出现的频率也高于骨髓穿刺。